Streetbeat News

Earnings

NVO

Novo Nordisk A/S (NYSE:NVO) shares fell over 6% after reporting Q2 2024 sales and EPS that missed analyst expectations. Despite shortfalls in Ozempic and Wegovy sales, Goldman Sachs maintains a positive outlook, suggesting current weakness could be a buying opportunity.

Portfolio Pulse from Piero Cingari

August 07, 2024 | 3:59 pm

NRC

National Research shares are trading lower after the company reported a year-over-year decrease for its Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 3:59 pm

VVI

Viad shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 3:55 pm

CNDT

Conduent Inc. (NASDAQ:CNDT) reported a 9.5% YoY revenue decline for Q2 2024, beating consensus estimates. Despite a beat on adjusted EPS loss, the company saw significant declines in adjusted EBITDA and operating cash flow. Conduent repurchased 43.3 million shares, including 38 million from Carl Icahn. The company revised its 2024 outlook downward, leading to a 9.52% drop in stock price.

Portfolio Pulse from Akanksha Bakshi

August 07, 2024 | 3:55 pm

ILMN

Illumina, Inc. (NASDAQ:ILMN) reported better-than-expected Q2 sales results, leading to increased price targets from analysts. Despite missing earnings estimates, the company's sales performance and strategic execution were praised. Shares rose 9.1% following the announcement.

Portfolio Pulse from Avi Kapoor

August 07, 2024 | 3:55 pm

WTI

W&T Offshore shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 3:55 pm

EGY

VAALCO Energy shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 3:48 pm

AMZN

RIVN

Rivian Automotive (NASDAQ:RIVN) received mixed reactions from analysts following its Q2 earnings report. Analysts highlighted partnerships with Volkswagen and Amazon, and the upcoming launch of R2 vehicles. Price targets ranged from $15 to $21, with a focus on profitability and production updates.

Portfolio Pulse from Chris Katje

August 07, 2024 | 3:47 pm

LDI

LoanDepot shares are trading higher following the release of their Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 3:47 pm

EBS

Emergent BioSolutions Inc. (NYSE:EBS) reported a significant decline in second-quarter 2024 sales and a deeper-than-expected adjusted EPS loss. Despite beating revenue expectations, the company updated its 2024 guidance to reflect higher losses and slightly increased revenue projections. The stock fell 38.5% following the announcement.

Portfolio Pulse from Vandana Singh

August 07, 2024 | 3:47 pm